KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Crescent Capital BDC (CCAP) EBITDA (2021 - 2025)

Crescent Capital BDC (CCAP) has disclosed EBITDA for 5 consecutive years, with -$149.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 828.39% year-over-year to -$149.1 million, compared with a TTM value of -$98.7 million through Dec 2025, down 210.84%, and an annual FY2025 reading of -$98.7 million, down 210.84% over the prior year.
  • EBITDA was -$149.1 million for Q4 2025 at Crescent Capital BDC, down from $101.1 million in the prior quarter.
  • Across five years, EBITDA topped out at $156.0 million in Q4 2023 and bottomed at -$149.1 million in Q4 2025.
  • Average EBITDA over 5 years is $7.6 million, with a median of -$13.7 million recorded in 2022.
  • The sharpest move saw EBITDA skyrocketed 452.95% in 2024, then tumbled 828.39% in 2025.
  • Year by year, EBITDA stood at -$79.2 million in 2021, then skyrocketed by 83.11% to -$13.4 million in 2022, then soared by 1265.77% to $156.0 million in 2023, then crashed by 86.88% to $20.5 million in 2024, then crashed by 828.39% to -$149.1 million in 2025.
  • Business Quant data shows EBITDA for CCAP at -$149.1 million in Q4 2025, $101.1 million in Q3 2025, and -$25.7 million in Q2 2025.